MedTrace Logo

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II

NCT03828279 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2019-02-05

No results posted yet for this study

Summary

The objective of this international hereditary angioedema (HAE) register is to collect homogeneous clinical and laboratory data on patients with HAE type I and II gathering better information on the natural course of the disease and detecting therapeutic options to manage it.

Conditions

  • Hereditary Angioedema Type I and II

Interventions

DIAGNOSTIC_TEST

functional and antigenic C1 inhibitor

Diagnosis of HAE is based on personal and/or family history of angioedema and on C1 inhibitor functional or antigenic plasma levels ≤50% of normal.

Sponsors & Collaborators

  • HAE Global Registry Foundation

    lead OTHER

Principal Investigators

  • marco cicardi, MD · HAE Global Registry Foundation

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2019-12-31
Completion
2023-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03828279 on ClinicalTrials.gov